A landmark study has revealed that an interleukin-17-like signaling system modulates a neural circuit that controls the aggregation behavior of nematodes.
Chemical neurotransmission connects neurons to form circuits that process information and generate behavior. Some neurotransmission occurs at specialized contacts between neuronssynapses -at which electrical activity in one neuron is rapidly and precisely transformed into chemical signals that impinge on its partner. Other neurochemical signals are not confined to synapses and can influence larger numbers of cellular targets over longer timescales. In this mode, chemical neurotransmission can alter the function of entire neural circuits to generate, select or modulate behavioral states. How this happens is a complicated and unresolved question of molecular signaling and circuit function, but neuroscientists have long thought that the identities of the neurochemicals that function as behavioral modulators is a settled issue. These molecules include small-molecule neurotransmitters, such as serotonin, acetylcholine and dopamine, and a defined set of neuropeptide transmitters. Through a tour de force genetic analysis of a modulated behavior in the nematode Caenorhabditis elegans, de Bono and colleagues [1] have recently added a new type of molecule to the pantheon of neuromodulators: cytokines related to pro-inflammatory signals of the immune system.
The function of cytokines as neuromodulators was discovered through studies of genes required for C. elegans behavior. This organism offers a remarkable opportunity to study the molecular mechanisms by which neurochemical signaling systems control behavior. On the one hand, the worm nervous system is famously simple, comprising only 302 neurons connected by a few thousand synapses [2] . On the other hand, the tiny brain of this microscopic animal uses almost every neurochemical found in the vertebrate brain and therefore neatly recapitulates the neurochemical complexity and diversity of larger nervous systems. The C. elegans genome encodes conserved neurotransmitter biosynthesis pathways, conserved neurotransmitter release mechanisms and conserved receptor systems for a host of small-molecule neurotransmitters (e.g. acetylcholine, glutamate, and monoamines such as serotonin and dopamine) [3, 4] . Genomic and proteomic analyses have revealed a striking number and diversity of another class of neurochemicals: peptide transmitters. The current tally of C. elegans neuropeptides exceeds 300, and they are encoded by more than 100 structural genes [5] [6] [7] [8] . As in larger nervous systems, C. elegans neurotransmission functions both within circuits delineated by synaptic connections and in extrasynaptic signaling networks [9] .
de Bono and colleagues [1] selected for their study one behavior that is a particularly excellent subject for genetic analysis of neuromodulation. C. elegans is remarkably sensitive to ambient oxygen concentrations and greatly prefers low oxygen levels of 8-10% to normal oxygen levels of 21% [10] . Specialized sensory neurons called URX, AQR and PQR monitor environmental oxygen concentrations and are required for behavioral responses to normoxia [10] . A preference for low oxygen is very likely adaptive for these bacterivorous nematodes, which in the wild are normally found in environments in which active microbial growth reduces ambient oxygen levels. When challenged with normal air containing 21% oxygen, most C. elegans strains display a striking behavior: nematodes come together to form clumps of worms in which oxygen levels are reduced by the respiration of the swarming nematodes [10, 11] . Aggregation behavior is potently inhibited by neuropeptides of the FMFRamide family signaling through the neuropeptide receptor NPR-1 [12, 13] . These neuropeptides do not inhibit the oxygen-sensing neurons that trigger aggregation. Instead, these peptides regulate the excitability of RMG interneurons, which are postsynaptic to oxygen sensors and function as highly connected hubs in locomotory circuits within the worm brain [14] .
To identify mechanisms that control aggregation behavior, de Bono and colleagues [1] isolated more than 800 C. elegans mutants defective in this behavior, sequenced their genomes, and identified loci that were repeatedly mutated in aggregation-defective mutants. Six mutants returned by this remarkable screen were defective for a cell-surface receptor with homology to vertebrate interleukin-17 (IL-17) receptors and that was accordingly named ILCR-1 (interleukin-17 cytokine receptor-like 1). Strikingly, members of a second complementation group of four alleles carried mutations in ilc-17.1, one of three genes in the C. elegans genome that encode IL-17-like factors. Elegant biochemical analysis showed that, together with a paralog, ILCR-2, ILCR-1 forms a heteromeric receptor for the cytokine-like factor ILC-17.1. Moreover, the corresponding mutants constitute a distinctive class of aggregation-defective mutants that display acute behavioral responses to oxygen stimuli but, unlike wild-type worms, fail to sustain these acute responses.
The unexpected discovery that a cytokine signaling pathway is required for modulated aggregation behavior raised several key questions. What part of the neural circuit that mediates aggregation is affected by mutation of this IL-17-like cytokine signaling system? Does this system play an instructive role in this circuit, for example as a neuromodulator, or is it required for proper development of the circuit? And what are the functionally relevant targets of cytokine receptors in this context? Incisive genetic analysis revealed that ILCR-1/2 receptors are required in the RMG interneurons, which are known substrates of peptidergic modulation in the control of aggregation behavior [14] . Moreover, in vivo calcium imaging revealed that mutation of cytokine signaling genes blunted the activation of RMG interneurons by oxygen stimuli without affecting the responses of presynaptic oxygen-sensing neurons. The authors next demonstrated that cytokine signaling plays an instructive role in the aggregation circuit; postdevelopmental expression of ILC-17.1 cytokine restored aggregation behavior to ilc-17.1 mutants within hours of induction of gene expression. And to answer the question of how cytokine receptors signal in RMG interneurons to modulate their function, the authors turned again to their vast repository of aggregation-defective mutants. Because ilcr-1 and ilc-17.1 mutants display a characteristic defect in oxygen responses, de Bono and colleagues [1] were able to sift through their mutant collection and identify other mutants with a similar behavioral defect. Eight such mutants were found and these defined three components of a signaling pathway coupled to cytokine receptors: ACTL-1, a homolog of the cytokine receptor-interacting protein Act1; PIK-1, a homolog of the Act1-associated protein kinase IRAK; and NFKI-1, a homolog of the atypical inhibitors of NFkB NFKBID and NFKBIZ. By analogy to vertebrate cytokine receptor signaling pathways, it is likely that IL-17-like cytokines modulate RMG interneurons by activating a transcriptional response. Despite the scope and depth of the genetic analysis that identified cytokines as neuromodulators, the identity of the transcriptional regulator at the end of this pathway remains a mystery. Even though many components of cytokine receptor signaling pathways are present in C. elegans, there is no nematode homolog of NFkB, the transcription factor that is typically involved in cytokine-induced transcriptional responses.
Hosts of exciting questions surround the discovery of a role for cytokines as neuromodulators. What is the endogenous source of IL-17-like cytokines, and what are the gene targets of IL-17 receptor signaling that alter the physiology and function of interneurons in the aggregation circuit? And what triggers the release of neuromodulatory cytokines in the C. elegans nervous system? The authors propose the tantalizing hypothesis that cytokine release in the C. elegans nervous system is caused by exposure to microbes. ILC-17.1 is expressed in neurons, and the authors suggest that detection of microbes by sensory neurons evokes cytokine release in a manner that echoes the triggering of pro-inflammatory cytokine release by activation of innate immunity in vertebrates. It is now understood that C. elegans relies heavily on sensory mechanisms to detect and evaluate the quality of environmental microbes, which might be food but might also be harmful pathogens. Sensory detection of microbes has been shown to underlie a learned pathogenavoidance behavior as well as innate pathogen-avoidance behaviors [15] [16] [17] [18] [19] . Together, these studies indicate that different parts of the nematode sensory nervous system function in pathogen sensing, indicating that this critical function is executed by multiple neural circuits under the control of distinct modulatory mechanisms.
Perhaps the most intriguing implication of the discovery that cytokines function as neuromodulators in the nematode nervous system is that they might play similar roles in the vertebrate brain. The authors note that IL-17 receptors are expressed by vertebrate neurons, opening the possibility that their function as regulators of neural activity might be evolutionarily conserved. The recent discovery that a maternal IL-17 response affects fetal brain development and can cause autism-like defects in offspring [20] indicates an important role for IL-17 cytokines in brain development, and further studies will determine whether they also function post-developmentally as modulators of vertebrate neural circuits and behavior.
